Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Palù G[au]:

Perspectives on immunotherapy via oncolytic viruses. Reale A et al. Infect Agent Cancer. (2019)

Testing for Cytomegalovirus in Pregnancy. Saldan A et al. J Clin Microbiol. (2017)

Ebola Virus Entry: From Molecular Characterization to Drug Discovery. Salata C et al. Viruses. (2019)

Search results

Items: 1 to 50 of 554

1.

Mycoplasma genitalium, a stealth female reproductive tract.

De Carvalho NS, Palú G, Witkin SS.

Eur J Clin Microbiol Infect Dis. 2019 Sep 14. doi: 10.1007/s10096-019-03707-8. [Epub ahead of print] Review.

PMID:
31522281
2.

A clinical trial investigating biodistribution and shedding of an oncolytic virus.

Reale A, Calistri A, Palù G.

EBioMedicine. 2019 Sep;47:4-5. doi: 10.1016/j.ebiom.2019.08.011. Epub 2019 Aug 13. No abstract available.

3.

In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment.

Telatin V, Nicoli F, Frasson C, Menegotto N, Barbaro F, Castelli E, Erne E, Palù G, Caputo A.

Front Cell Infect Microbiol. 2019 Jun 14;9:190. doi: 10.3389/fcimb.2019.00190. eCollection 2019.

4.

Collaborative national multicenter for the identification of conversion factors from copies/mL to international units/mL for the normalization of HCMV DNA load.

Sidoti F, Piralla A, Costa C, Scarasciulli ML, Calvario A, Conaldi PG, Paba P, Perno CF, Gaeta A, Antonelli G, Sodano G, Santangelo R, Sanguinetti M, Vatteroni ML, Barzon L, Palù G, Abbate I, Capobianchi MR, Piccirilli G, Lazzarotto T, Baldanti F, Cavallo R.

Diagn Microbiol Infect Dis. 2019 Oct;95(2):152-158. doi: 10.1016/j.diagmicrobio.2019.05.012. Epub 2019 May 25.

PMID:
31204110
5.

Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: complexity and vaccine implications.

Parisi SG, Basso M, Scaggiante R, Andreis S, Mengoli C, Cruciani M, Del Vecchio C, Menegotto N, Zago D, Sarmati L, Andreoni M, Palù G.

BMC Public Health. 2019 May 28;19(1):645. doi: 10.1186/s12889-019-7004-x.

6.

New Frontiers of Corneal Gene Therapy.

Di Iorio E, Barbaro V, Alvisi G, Trevisan M, Ferrari S, Masi G, Nespeca P, Ghassabian H, Ponzin D, Palù G.

Hum Gene Ther. 2019 Aug;30(8):923-945. doi: 10.1089/hum.2019.026. Epub 2019 May 30.

PMID:
31020856
7.

Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia.

Salata C, Sgarabotto D, Del Vecchio C, Solimbergo E, Marini G, Nicolè S, Franchin E, Parolin C, Calistri A, Palù G.

J Infect Chemother. 2019 Jul;25(7):543-546. doi: 10.1016/j.jiac.2018.11.008. Epub 2019 Apr 20.

PMID:
31014561
8.

Improving the stability of the TetR/Pip-OFF mycobacterial repressible promoter system.

Boldrin F, Anoosheh S, Serafini A, Cioetto Mazzabò L, Palù G, Provvedi R, Manganelli R.

Sci Rep. 2019 Apr 8;9(1):5783. doi: 10.1038/s41598-019-42319-2.

9.

Ebola Virus Entry: From Molecular Characterization to Drug Discovery.

Salata C, Calistri A, Alvisi G, Celestino M, Parolin C, Palù G.

Viruses. 2019 Mar 19;11(3). pii: E274. doi: 10.3390/v11030274. Review.

10.

Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance.

Nannetti G, Massari S, Mercorelli B, Bertagnin C, Desantis J, Palù G, Tabarrini O, Loregian A.

Antiviral Res. 2019 May;165:55-64. doi: 10.1016/j.antiviral.2019.03.003. Epub 2019 Mar 15.

PMID:
30885750
11.

Assessing the role of Rv1222 (RseA) as an anti-sigma factor of the Mycobacterium tuberculosis extracytoplasmic sigma factor SigE.

Boldrin F, Mazzabò LC, Anoosheh S, Palù G, Gaudreau L, Manganelli R, Provvedi R.

Sci Rep. 2019 Mar 14;9(1):4513. doi: 10.1038/s41598-019-41183-4.

12.

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach.

Mengoli C, Basso M, Andreis S, Scaggiante R, Cruciani M, Ferretto R, Panese S, Manfrin V, Francisci D, Schiaroli E, Maffongelli G, Sarmati L, Andreoni M, Baldelli F, Palu' G, Parisi SG.

PLoS One. 2019 Mar 11;14(3):e0213160. doi: 10.1371/journal.pone.0213160. eCollection 2019.

13.

Perspectives on immunotherapy via oncolytic viruses.

Reale A, Vitiello A, Conciatori V, Parolin C, Calistri A, Palù G.

Infect Agent Cancer. 2019 Feb 11;14:5. doi: 10.1186/s13027-018-0218-1. eCollection 2019. Review.

14.

The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity.

Luganini A, Mercorelli B, Messa L, Palù G, Gribaudo G, Loregian A.

Antiviral Res. 2019 Apr;164:52-60. doi: 10.1016/j.antiviral.2019.02.006. Epub 2019 Feb 8.

PMID:
30738836
16.

Detection of hepatitis C virus in an exhumed body identified the origin of a nosocomial transmission that caused multiple fatal diseases.

McDermott J, Parisi SG, Martini I, Boldrin C, Franchin E, Dal Bello F, Gianelli Castiglione A, Boeri E, Sampaolo M, Basso M, Menegazzi P, Tagliaferro L, Palù G, Varnier OE.

J Hosp Infect. 2019 Jul;102(3):332-336. doi: 10.1016/j.jhin.2019.01.004. Epub 2019 Jan 8.

PMID:
30633945
17.

Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study.

Basso M, Andreis S, Scaggiante R, Franchin E, Zago D, Biasolo MA, Del Vecchio C, Mengoli C, Sarmati L, Andreoni M, Palù G, Parisi SG.

BMC Infect Dis. 2018 Dec 19;18(1):683. doi: 10.1186/s12879-018-3591-x.

18.

G-quadruplex forming sequences in the genome of all known human viruses: A comprehensive guide.

Lavezzo E, Berselli M, Frasson I, Perrone R, Palù G, Brazzale AR, Richter SN, Toppo S.

PLoS Comput Biol. 2018 Dec 13;14(12):e1006675. doi: 10.1371/journal.pcbi.1006675. eCollection 2018 Dec.

19.

Human papillomavirus infection is not involved in esophageal verrucous carcinoma.

Cappellesso R, Coati I, Barzon L, Peta E, Masi G, Scarpa M, Lanza C, Michelotto M, Ruol A, Cesaro S, Castoro C, Palù G, Nuovo GJ, Fassan M, Rugge M.

Hum Pathol. 2019 Mar;85:50-57. doi: 10.1016/j.humpath.2018.10.024. Epub 2018 Nov 10.

PMID:
30423307
20.

Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction.

D'Agostino I, Giacchello I, Nannetti G, Fallacara AL, Deodato D, Musumeci F, Grossi G, Palù G, Cau Y, Trist IM, Loregian A, Schenone S, Botta M.

Eur J Med Chem. 2018 Sep 5;157:743-758. doi: 10.1016/j.ejmech.2018.08.032. Epub 2018 Aug 13.

PMID:
30142611
21.

Sixth European Seminar in Virology on Virus⁻Host Interaction at Single Cell and Organism Level.

Saccon E, Vitiello A, Trevisan M, Salata C, Palù G.

Viruses. 2018 Jul 28;10(8). pii: E400. doi: 10.3390/v10080400.

22.

A first molecular characterization of Listeria monocytogenes isolates circulating in humans from 2009 to 2014 in the Italian Veneto region.

Salata C, Lisotto P, Boldrin C, De Canale E, Piccirillo A, Calistri A, Palù G.

New Microbiol. 2018 Jul;41(3):232-234. Epub 2018 Jul 20.

23.

Corrigendum to "Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity" [Eur. J. Med. Chem. 138 (2017) 128-139].

Desantis J, Nannetti G, Massari S, Barreca ML, Manfroni G, Cecchetti V, Palù G, Goracci L, Loregian A, Tabarrini O.

Eur J Med Chem. 2018 Aug 5;156:302-303. doi: 10.1016/j.ejmech.2018.07.009. Epub 2018 Jul 11. No abstract available.

PMID:
30007243
24.

Recent developments in vaccines and biological therapies against Japanese encephalitis virus.

Barzon L, Palù G.

Expert Opin Biol Ther. 2018 Aug;18(8):851-864. doi: 10.1080/14712598.2018.1499721. Epub 2018 Jul 19. Review.

PMID:
29991325
25.

Oral Mucosa-Derived Induced Pluripotent Stem Cells from Patients with Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.

Trevisan M, Alvisi G, Barbaro V, Barzon L, Raffa P, Migliorati A, Desole G, Ruzittu S, Masi G, Di Iorio E, Palù G.

Cell Reprogram. 2018 Aug;20(4):215-224. doi: 10.1089/cell.2017.0064. Epub 2018 Jul 10.

PMID:
29989433
26.

A sensitive and validated HPLC-UV method for the quantitative determination of the new antifungal drug isavuconazole in human plasma.

Nannetti G, Pagni S, Palù G, Loregian A.

Biomed Chromatogr. 2018 Nov;32(11):e4333. doi: 10.1002/bmc.4333. Epub 2018 Sep 11.

PMID:
29978912
27.

Evidence that Enterobius vermicularis plays a causative role for PFAPA and recurrent aphthous stomatitis.

Polese L, Besutti V, Muraro A, Palù G.

Minerva Med. 2018 Dec;109(6):498-500. doi: 10.23736/S0026-4806.18.05709-9. Epub 2018 May 31. No abstract available.

PMID:
29856193
28.

Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy.

Errico G, Gagliotti C, Monaco M, Masiero L, Gaibani P, Ambretti S, Landini MP, D'Arezzo S, Di Caro A, Parisi SG, Palù G, Vespasiano F, Morsillo F, Moro ML, Procaccio F, Ricci A, Grossi PA, Pantosti A, Nanni Costa A; SInT Collaborative Study Group.

Clin Microbiol Infect. 2019 Feb;25(2):203-209. doi: 10.1016/j.cmi.2018.05.003. Epub 2018 May 22.

PMID:
29800674
29.

Drug Repurposing for Viral Infectious Diseases: How Far Are We?

Mercorelli B, Palù G, Loregian A.

Trends Microbiol. 2018 Oct;26(10):865-876. doi: 10.1016/j.tim.2018.04.004. Epub 2018 May 11. Review.

PMID:
29759926
30.

Contribution of the residue at position 4 within classical nuclear localization signals to modulating interaction with importins and nuclear targeting.

Smith KM, Di Antonio V, Bellucci L, Thomas DR, Caporuscio F, Ciccarese F, Ghassabian H, Wagstaff KM, Forwood JK, Jans DA, Palù G, Alvisi G.

Biochim Biophys Acta Mol Cell Res. 2018 Aug;1865(8):1114-1129. doi: 10.1016/j.bbamcr.2018.05.006. Epub 2018 May 8.

31.

A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells.

Messa L, Celegato M, Bertagnin C, Mercorelli B, Nannetti G, Palù G, Loregian A.

Sci Rep. 2018 Apr 16;8(1):6020. doi: 10.1038/s41598-018-24470-4.

32.

Reply to Fontaine.

Barzon L, Percivalle E, Pacenti M, Rovida F, Zavattoni M, Del Bravo P, Cattelan AM, Palù G, Baldanti F.

Clin Infect Dis. 2018 Sep 14;67(7):1144-1145. doi: 10.1093/cid/ciy262. No abstract available.

PMID:
29617958
33.

Herpes Simplex Virus Type 1 Infects Enteric Neurons and Triggers Gut Dysfunction via Macrophage Recruitment.

Brun P, Qesari M, Marconi PC, Kotsafti A, Porzionato A, Macchi V, Schwendener RA, Scarpa M, Giron MC, Palù G, Calistri A, Castagliuolo I.

Front Cell Infect Microbiol. 2018 Mar 15;8:74. doi: 10.3389/fcimb.2018.00074. eCollection 2018.

34.

Intersectin goes nuclear: secret life of an endocytic protein.

Alvisi G, Paolini L, Contarini A, Zambarda C, Di Antonio V, Colosini A, Mercandelli N, Timmoneri M, Palù G, Caimi L, Ricotta D, Radeghieri A.

Biochem J. 2018 Apr 27;475(8):1455-1472. doi: 10.1042/BCJ20170897.

PMID:
29599122
35.

Generation of a transgene-free human induced pluripotent stem cell line (UNIPDi001-A) from oral mucosa epithelial stem cells.

Alvisi G, Trevisan M, Masi G, Canel V, Caenazzo L, Nespeca P, Barzon L, Di Iorio E, Barbaro V, Palù G.

Stem Cell Res. 2018 Apr;28:177-180. doi: 10.1016/j.scr.2018.02.007. Epub 2018 Feb 18.

36.

Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.

Parisi SG, Andreis S, Mengoli C, Menegotto N, Cavinato S, Scaggiante R, Andreoni M, Palù G, Basso M, Cattelan AM.

Med Microbiol Immunol. 2018 Aug;207(3-4):183-194. doi: 10.1007/s00430-018-0538-1. Epub 2018 Mar 9.

PMID:
29523966
37.

Molecular Requirements for Self-Interaction of the Respiratory Syncytial Virus Matrix Protein in Living Mammalian Cells.

Trevisan M, Di Antonio V, Radeghieri A, Palù G, Ghildyal R, Alvisi G.

Viruses. 2018 Mar 3;10(3). pii: E109. doi: 10.3390/v10030109.

38.

Amiodarone affects Ebola virus binding and entry into target cells.

Salata C, Munegato D, Martelli F, Parolin C, Calistri A, Baritussio A, Palù G.

New Microbiol. 2018 Apr;41(2):162-164. Epub 2018 Mar 2.

39.

Generation of a transgene-free induced pluripotent stem cells line (UNIPDi002-A) from oral mucosa epithelial stem cells carrying the R304Q mutation in TP63 gene.

Trevisan M, Barbaro V, Riccetti S, Masi G, Barzon L, Nespeca P, Alvisi G, Di Iorio E, Palù G.

Stem Cell Res. 2018 Apr;28:149-152. doi: 10.1016/j.scr.2018.02.006. Epub 2018 Feb 16.

40.

Induced pluripotent stem cells line (UNIPDi003-A) from a patient affected by EEC syndrome carrying the R279H mutation in TP63 gene.

Trevisan M, Di Iorio E, Masi G, Riccetti S, Barzon L, Alvisi G, Caenazzo L, Barbaro V, Palù G.

Stem Cell Res. 2018 Apr;28:141-144. doi: 10.1016/j.scr.2018.02.008. Epub 2018 Feb 16.

41.

HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.

Peta E, Sinigaglia A, Masi G, Di Camillo B, Grassi A, Trevisan M, Messa L, Loregian A, Manfrin E, Brunelli M, Martignoni G, Palù G, Barzon L.

Oncogene. 2018 Mar;37(12):1654-1668. doi: 10.1038/s41388-017-0083-1. Epub 2018 Jan 16.

PMID:
29335520
42.

Virus and Antibody Dynamics in Travelers With Acute Zika Virus Infection.

Barzon L, Percivalle E, Pacenti M, Rovida F, Zavattoni M, Del Bravo P, Cattelan AM, Palù G, Baldanti F.

Clin Infect Dis. 2018 Apr 3;66(8):1173-1180. doi: 10.1093/cid/cix967.

PMID:
29300893
43.

Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein.

Mercorelli B, Luganini A, Celegato M, Palù G, Gribaudo G, Loregian A.

Antiviral Res. 2018 Feb;150:130-136. doi: 10.1016/j.antiviral.2017.12.014. Epub 2017 Dec 22.

PMID:
29274844
44.

A sterilization method for decellularized xenogeneic cardiovascular scaffolds.

Fidalgo C, Iop L, Sciro M, Harder M, Mavrilas D, Korossis S, Bagno A, Palù G, Aguiari P, Gerosa G.

Acta Biomater. 2018 Feb;67:282-294. doi: 10.1016/j.actbio.2017.11.035. Epub 2017 Dec 2.

PMID:
29183849
45.

Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.

Brun P, Scarpa M, Marchiori C, Sarasin G, Caputi V, Porzionato A, Giron MC, Palù G, Castagliuolo I.

PLoS One. 2017 Nov 17;12(11):e0188563. doi: 10.1371/journal.pone.0188563. eCollection 2017.

46.

Hepatitis E virus infection in North Italy: high seroprevalence in swine herds and increased risk for swine workers.

Mughini-Gras L, Angeloni G, Salata C, Vonesch N, D'Amico W, Campagna G, Natale A, Zuliani F, Ceglie L, Monne I, Vascellari M, Capello K, DI Martino G, Inglese N, Palù G, Tomao P, Bonfanti L.

Epidemiol Infect. 2017 Dec;145(16):3375-3384. doi: 10.1017/S0950268817002485. Epub 2017 Nov 17.

PMID:
29145911
47.

Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.

Rockstroh A, Moges B, Barzon L, Sinigaglia A, Palù G, Kumbukgolla W, Schmidt-Chanasit J, Sarno M, Brites C, Moreira-Soto A, Drexler JF, Ferreira OC, Ulbert S.

Emerg Microbes Infect. 2017 Nov 8;6(11):e99. doi: 10.1038/emi.2017.87.

48.

Genome editing technologies to fight infectious diseases.

Trevisan M, Palù G, Barzon L.

Expert Rev Anti Infect Ther. 2017 Nov;15(11):1001-1013. doi: 10.1080/14787210.2017.1400379. Epub 2017 Nov 8. Review.

PMID:
29090592
49.

Promoter mutagenesis for fine-tuning expression of essential genes in Mycobacterium tuberculosis.

Boldrin F, Degiacomi G, Serafini A, Kolly GS, Ventura M, Sala C, Provvedi R, Palù G, Cole ST, Manganelli R.

Microb Biotechnol. 2018 Jan;11(1):238-247. doi: 10.1111/1751-7915.12875. Epub 2017 Oct 27.

50.

The Alternative Sigma Factors SigE and SigB Are Involved in Tolerance and Persistence to Antitubercular Drugs.

Pisu D, Provvedi R, Espinosa DM, Payan JB, Boldrin F, Palù G, Hernandez-Pando R, Manganelli R.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01596-17. doi: 10.1128/AAC.01596-17. Print 2017 Dec.

Supplemental Content

Support Center